Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/29/2012WO2012138857A9 Methods and materials for reducing supression of immune function
11/29/2012WO2012138147A3 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof
11/29/2012WO2012138043A3 Therapeutic composition containing endothelin as an active component
11/29/2012WO2012136873A3 Triazine derivatives and their uses as trpv1 inhibitors
11/29/2012WO2012135757A3 Methods for treating cancer
11/29/2012WO2012135714A3 Serine biosynthesis pathway inhibition for treatment of cancer
11/29/2012WO2012134206A3 Process for the preparation of anhydrous aripiprazole crystal form ii
11/29/2012WO2012131707A3 Crystalline form of bortezomib, preparation method and pharmaceutical composition there f
11/29/2012WO2012131463A3 Controlled release pharmaceutical dosage forms
11/29/2012WO2012129513A3 Blockage of pai-1 in diabetic cd34+ stem cells corrects cellular dysfunction
11/29/2012WO2012129365A4 Myelin regeneration with androgens
11/29/2012WO2012125623A3 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
11/29/2012WO2012111025A4 1,2,3-triazole containing artemisinin compounds and process for preparation thereof
11/29/2012WO2012104823A3 Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
11/29/2012WO2012102937A3 Benz imidazole compounds that expand hematopoietic stem cells
11/29/2012WO2012097258A3 Formulations for the prevention and treatment of wolbachia-related disease
11/29/2012WO2012087976A3 Novel inhibitors of hepatitis c virus replication
11/29/2012WO2012021107A3 A liposomal formulation for ocular drug delivery
11/29/2012WO2011156897A3 Polymorphic forms of rifaximin
11/29/2012WO2011140682A8 (2e)-3-phenyl-n-[2,2,2-trifluoro-1-[[(8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof
11/29/2012WO2011131943A8 Pharmaceutical compositions
11/29/2012WO2011128627A8 Oral veterinary pharmaceutical and nutraceutical compositions
11/29/2012WO2011119610A3 (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3
11/29/2012WO2011088073A3 Personal care compositions comprising a methyl naphthalenyl ketone or a derivative thereof
11/29/2012WO2009027762A3 Liquid dosage forms of fluoroquinolone antibiotics or salt thereof for ophthalmic, otic and nasal administration
11/29/2012US20120304318 Cancer diagnosis and treatment
11/29/2012US20120303115 Expandable devices coated with a rapamycin composition
11/29/2012US20120302816 Therapeutic compositions and methods for targeted delivery of active agents
11/29/2012US20120302794 Derivatives of venlafaxine and methods of preparing and using the same
11/29/2012US20120302750 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
11/29/2012US20120302646 Use of Cannabidiol in the Treatment of Hepatitis
11/29/2012US20120302645 Use of hydroxytyrosol for improving muscle differentiation
11/29/2012US20120302644 Adhesive patch for treatment of tinea unguium
11/29/2012US20120302643 Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol Hydrochloride
11/29/2012US20120302641 Biphenyl derivatives useful as glucagon receptor antagonists
11/29/2012US20120302640 Oral formulations
11/29/2012US20120302639 Omega 3 formulations for treatment of risk factors for cardiovascular disease and protection against sudden death
11/29/2012US20120302638 Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
11/29/2012US20120302637 Methods of Treating Tachycardia and/or Controlling Heart Rate While Minimizing and/or Controlling Hypotension
11/29/2012US20120302636 Method of treating a disorder associated with mtp
11/29/2012US20120302634 Skin protection compositions, in particular cream to protect against cold
11/29/2012US20120302633 Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester
11/29/2012US20120302632 Dietary control of arachidonic acid metabolism
11/29/2012US20120302631 Inhibitors of PFKFB3 for Cancer Therapy
11/29/2012US20120302630 Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof
11/29/2012US20120302629 Biomarkers for gossypol chemotherapy and methods of treating disease
11/29/2012US20120302628 Oligonucleotides which inhibit p53 induction in response to cellular stress
11/29/2012US20120302627 Method of using adenoviral vectors to induce an immune response
11/29/2012US20120302626 Microrna and use thereof in identification of b cell malignancies
11/29/2012US20120302624 Biomarker for identifying subgroup of early-stage lung adenocarcinoma patients
11/29/2012US20120302623 Novel Activation and Transfer Cascade for Ubiquitin
11/29/2012US20120302622 Conjugates, particles, compositions, and related methods
11/29/2012US20120302621 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders
11/29/2012US20120302620 Novel pyrone-indole derivatives and process for their preparation
11/29/2012US20120302619 Novel 1-aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
11/29/2012US20120302618 Use of benzydamine in the treatment of p40-dependent diseases
11/29/2012US20120302617 Phenyl and Benzodioxinyl Substituted Indazoles Derivatives
11/29/2012US20120302616 Method of treatment of obsessive compulsive disorder with ondansetron
11/29/2012US20120302615 Method of treatment of cns disorders
11/29/2012US20120302614 Method for improving cerebral circulation or treating a cerebral blood flow disorder
11/29/2012US20120302613 Novel antibiotics
11/29/2012US20120302612 Novel thiazolidin-4-one derivatives
11/29/2012US20120302610 Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists
11/29/2012US20120302609 Pyrazolines for the Modulation of PKM2
11/29/2012US20120302608 Novel Imidazole Derivatives Useful for the Treatment of Arthritis
11/29/2012US20120302607 C4-substituted alpha-keto oxazoles
11/29/2012US20120302606 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
11/29/2012US20120302605 3-deutero-pomalidomide
11/29/2012US20120302604 Modulation of Phospholipase D for the Treatment of the Acute and Chronic Effects of Ethanol
11/29/2012US20120302603 Amyloid binding agents
11/29/2012US20120302602 Vanilloid Receptor Ligand Compounds, Pharmaceutical Compositions Containing Them, a Method of Producing Them and the Use Thereof to Treat Pain and Various Other Conditions
11/29/2012US20120302601 Compositions and methods for the treatment of macular degeneration
11/29/2012US20120302600 Stable laquinimod preparations
11/29/2012US20120302599 KAT ll INHIBITORS
11/29/2012US20120302598 Imidazopyridinones
11/29/2012US20120302597 Novel p2x7r antagonists and their use
11/29/2012US20120302596 Azaindoles having serotonin receptor affinity
11/29/2012US20120302595 Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
11/29/2012US20120302594 Quaternary opioid carboxamides
11/29/2012US20120302593 Use of at Least One Isoquinoline Compound of Formula I, Pharmaceutical Composition for Treating or Preventing Neurodegenerative Diseases and Method for Treating or Preventing Neurodegenerative Diseases
11/29/2012US20120302592 Topiramate plus naltrexone for the treatment of addictive disorders
11/29/2012US20120302591 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
11/29/2012US20120302590 Methods and compositions to prevent addiction
11/29/2012US20120302589 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
11/29/2012US20120302588 Method of enhancing hair growth
11/29/2012US20120302587 Rho-kinase inhibitors
11/29/2012US20120302586 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
11/29/2012US20120302585 Inhibitors of fatty acid uptake and methods of use
11/29/2012US20120302584 Novel salts forms of pyrimidin-5-yl acetic acid derivative
11/29/2012US20120302583 New Compounds I
11/29/2012US20120302582 Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
11/29/2012US20120302581 Methods and Compositions for the Treatment of RAS Associated Disorders
11/29/2012US20120302580 Optically active compound of prulifloxacin for treating infection and preparation method thereof
11/29/2012US20120302579 Cancer treatment method
11/29/2012US20120302578 Aminooxazole Inhibitors of Cyclin Dependent Kinases
11/29/2012US20120302577 Treatment of gist with masitinib
11/29/2012US20120302576 Ampk modulators
11/29/2012US20120302575 Methods for Preventing Oxidative Stress Injury of a Tissue by a Folate-Tempol Conjugate.
11/29/2012US20120302574 Methods of Preventing and Reducing the Severity of Stress-Associated Conditions
11/29/2012US20120302573 Methods of inhibiting pro matrix metalloproteinase activation
1 ... 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 ... 7860